Coral Rosado-Santiago, Carmen L Pérez-Guerra, Nicole M Vélez-Agosto, Claudia Colón-Burgos, Karla M Marrero-Santos, Susanna K Partridge, Amy E Lockwood, Cathy Young, Steve H Waterman, Gabriela Paz-Bailey, Iris Cardona-Gerena, Angel Rivera, Laura E Adams, Joshua M Wong
Dengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9-16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key informants (i.e. practicing pediatricians, physicians from immunization clinics, university researchers, and school officials) in Puerto Rico (P.R.) to examine acceptability, barriers, and motivators to vaccinate with Dengvaxia...
December 31, 2024: Human Vaccines & Immunotherapeutics